Journal decision profile

Oncology-New York

Medicine

Oncology-New York's 2026 Journal Metrics Score is 0.7, ranking Q3 in Economics and Econometrics. Two-year citation average from OpenAlex data, updated August 2026.

United StatespISSN 0890-9091eISSN 2767-7389
Checking system sharing availability.Visit homepage

Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.

Journal Metrics Score
i
Journal Metrics ScoreThe raw score is citations received in the latest complete year by works from the two previous years, divided by the number of those works. It is calculated from OpenAlex open data (CC0) and is not a percentage grade.
2026
0.7

Journal Metrics Score 2026 · 2021–2024 window citedness 1.10.

Submission-to-acceptance
i
Submission-to-acceptanceCalendar days between the received and accepted dates reported in recent PubMed records. This interval includes editorial handling and author revisions, so it is not time to first decision or pure peer-review time.
PUBMED

Not available — there are not enough recent PubMed records with both received and accepted dates.

Indicative APC
i
Indicative APCThis journal-level estimate comes from the OpenAlex source record. It is not a verified quote and may exclude taxes, waivers, society discounts, or article-type charges. Check the journal's official website before deciding.
OPENALEX · VERIFY
Not available

No journal-level APC is available in the current OpenAlex snapshot. Cost is excluded from scoring.

Free preview · no sign-in

Does your manuscript fit Oncology-New York?

Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.

Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.

At a glance

Journal decision profile

Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.

Relative profile

Metrics ScoreThe raw 2026 Journal Metrics Score is the recent two-year citation average shown above. The radar converts it to a 0–100 cohort percentile: farther out means a higher score than more comparable journals. It is not a percentage grade.iSource outputThe raw rank compares lifetime output inside the journal’s leading-topic source set. The radar then compares that rank position across Decision Profile journals in the same primary OpenAlex field; when that field has too few profiles, it uses the broader profile set. Farther out means relatively more output, not better research quality.iTop 10% shareThe share of recent papers in the global top 10% for citations after comparing papers of the same type, publication year, and subfield. The radar converts that share to a 0–100 cohort percentile; it does not predict how a new paper will perform.iMedian FWCICitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected citation level for comparable papers; the radar shows its 0–100 cohort percentile.iOutput volumeAverage works published per year in the recent analysis window, converted to a 0–100 cohort percentile. Farther out means the journal publishes more papers; it does not mean those papers are better.i
Cost is intentionally excluded. Missing APC data is never converted to a zero-dollar fee or a fabricated cost score.

Raw values behind the shape

Always visible
Metrics Score
i
Metrics ScoreThe 2026 raw Journal Metrics Score shown above. The bar is its 0–100 percentile within the radar's comparable journal cohort; it is not a percentage score.
0.72026 · OPENALEX
Source output rank
i
Source output rankThis lifetime journal-wide output rank compares works published by the OpenAlex source with sources associated with the journal’s leading topic. More output does not mean higher quality.
#715 / 1,733LIFETIME OUTPUT
Highly cited papers
i
Highly cited papersShare of recent works in the global top 10% for citations after comparing papers of the same type, publication year, and subfield.
4.8%FIELD-NORMALIZED TOP 10%
Field-normalized impact
i
Field-normalized impactCitation performance of the middle recent paper after field, year, and work type are considered. A raw FWCI of 1.0 is the expected level for comparable work.
0.28MEDIAN FWCI
Submission-to-acceptance
i
Submission-to-acceptanceReceived-to-accepted calendar days from qualified PubMed records. It includes editorial handling and author revisions; it is not time to first decision or pure peer-review time.
—NOT AVAILABLE
Recent output
i
Recent outputAverage works published per year across the complete analysis window. This is a volume measure, not a quality score.
52 / yr2021–2024 AVG
Field-normalized top 10% share4.8%

10 of 207 works · same type, year & subfield

Field-normalized top 1% share0%

0 works · same type, year & subfield

Median FWCI0.28×

Below field-year expectation

Source output rank#715

of 1,733 topic-associated OpenAlex sources by lifetime output

What does Median FWCI mean?

FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.28, so its typical recent paper runs about 72% below its field benchmark.

What does Top 10% Share mean?

4.8% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.

Publishing pattern

Publication volume and article mix

Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.

Works published by year

OpenAlex source records · 2015–2025

22015
32016
12018
32019
782020
772021
552022
442023
312024
352025

Recent work-type mix

207 OpenAlex works · 2021–2024

Article77.8%
Paratext21.3%
Conference abstract0.5%
Review0.5%
OpenAlex article is broader than “original research.” PubMed Publication Types can add case-report and clinical-study detail.
Fit signals

Topics and medical subject coverage

OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.

Major MeSH signals

PubMed-indexed works

Select a MeSH signal to see how much Oncology-New York publishes on it, from PubMed counts for the last five complete years.

Leading OpenAlex topics

2021–2024 works
Lymphoma Diagnosis and Treatment14
Multiple Myeloma Research and Treatments10
Cancer survivorship and care6
Colorectal Cancer Treatments and Studies6
Prostate Cancer Diagnosis and Treatment6
Bladder and Urothelial Cancer Treatments5
Breast Cancer Treatment Studies4
Cancer Genomics and Diagnostics4
Cancer Immunotherapy and Biomarkers4
Lung Cancer Treatments and Mutations4
Methodology: OpenAlex snapshot 2026-10-19. FWCI, percentile badges, topics, and type mix use 207 works published 2021–2024. Radar normalization is versioned in the cached profile, and no cost score is assigned without reliable APC data.

Subject Category Quartiles

Quartiles computed within each OpenAlex subfield
CategoryQuartile
OncologyQ4
Cancer ResearchQ4
Pathology and Forensic MedicineQ4
Economics and EconometricsQ3

Is Oncology-New York a good journal?

A mid-ranked Q3 journal by citation data

By citation data, Oncology-New York is a mid-ranked journal: it is Q3 in Economics and Econometrics, the third quarter of journals by score, below the subfield median, and ranks #790 of 897 Oncology journals by Journal Metrics Score (top 89%). Oncology-New York's 2026 Journal Metrics Score is 0.7. OpenAlex classifies its papers in subfields including Oncology, Cancer Research, and Pathology and Forensic Medicine, so check that your topic fits its scope.

Best quartile
Q3
Economics and Econometrics
Rank in Oncology
#790 of 897
Top 89%
2026 Journal Metrics Score
0.7
Acceptance rate
Not published
By the journal or publisher
Papers published in 2025
35
OpenAlex works

Check before you submit

  • Confirm the journal is indexed where your institution or funder requires (for example Scopus or PubMed) before you submit.

Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.

Q3
Subfield Quartile
N/A
CAS Block

Ranking and source check

#790
of 897 Oncology field journals
#176
among Q3 Oncology journals

Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.

Journal Details

OpenAlex Works
365
H-Index
15
Fully Open Access
No
Recent OA Works
73
Subject Areas
OncologyCancer ResearchPathology and Forensic MedicineEconomics and Econometrics

Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.

How to submit to Oncology-New York

  1. 1

    Check the scope

    OpenAlex classifies Oncology-New York's papers in subfields including Oncology, Cancer Research, and Pathology and Forensic Medicine. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.

  2. 2

    Follow the author guidelines

    Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.

    Oncology-New York homepage ↗
  3. 3

    Submit online

    Use the submit link in Oncology-New York's author guidelines. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.

  4. 4

    Plan for costs

    OpenAlex has no article processing charge on record. Check the journal website for page charges or an optional open-access fee.

  5. 5

    Know what to expect

    Oncology-New York does not publish an acceptance rate.

New on PubMed

What's new in your field?

Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.

See a demo:GLP-1CRISPRLong COVID

Reviewer Two · coming soon

Know what reviewers will say before you submit to Oncology-New York

An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.

See what the report covers

Common questions about Oncology-New York

Is Oncology-New York a good journal?

By citation data, Oncology-New York is a mid-ranked journal: it is Q3 in Economics and Econometrics, the third quarter of journals by score, below the subfield median, and ranks #790 of 897 Oncology journals by Journal Metrics Score (top 89%). Oncology-New York's 2026 Journal Metrics Score is 0.7. OpenAlex classifies its papers in subfields including Oncology, Cancer Research, and Pathology and Forensic Medicine, so check that your topic fits its scope.

What is Oncology-New York's Journal Metrics Score in 2026?

Oncology-New York's 2026 Journal Metrics Score is 0.7, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.

What is the acceptance rate of Oncology-New York?

We have not found an official acceptance rate published by Oncology-New York or its publisher, and Journal Metrics does not estimate one because submission counts are not public. To judge selectivity, compare Oncology-New York's quartile and score with similar journals, or ask the editorial office.

What quartile is Oncology-New York in?

Oncology-New York's best quartile is Q3. By OpenAlex subfield: Q4 in Oncology; Q4 in Cancer Research; Q4 in Pathology and Forensic Medicine; Q3 in Economics and Econometrics. Quartiles rank journals by Journal Metrics Score within each subfield.

Is the Journal Metrics Score the same as other journal citation metrics?

No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Oncology-New York will not match this score exactly. Compare journals using one source at a time.

Which journals are alternatives to Oncology-New York?

Comparable journals include Cancer Pathogenesis and Therapy, World Journal of Oncology, Memo-Magazine of European Medical Oncology, and Nature Reviews Clinical Oncology. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.

How do I submit a paper to Oncology-New York?

Submit online through the link in Oncology-New York's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter.

Cite an article from this journal
Back to Search